
Antiva10 mg
Square Pharmaceuticals PLC.
Adefovir Dipivoxil is indicated for the treatment of chronic hepatitis B (CHB) in adults and adolescents 12 years of age and older who have evidence of active viral replication together with either…
Adefovir Dipivoxil is indicated for the treatment of chronic hepatitis B (CHB) in adults and adolescents 12 years of age and older who have evidence of active viral replication together with either persistently elevated serum aminotransferase levels (ALT or AST) or histologically active liver disease.
The recommended dose is described per indication and renal function below.
Adefovir Dipivoxil 10 mg is taken orally once daily, with or without food.
| Creatinine clearance | Adefovir Dipivoxil dosing |
|---|---|
| ≥50 mL/min | 10 mg every 24 hours |
| 30–49 mL/min | 10 mg every 48 hours |
| 10–29 mL/min | 10 mg every 72 hours |
| Hemodialysis patients | 10 mg every 7 days, administered following completion of a dialysis session |
No dosing recommendation is available for non-hemodialysis patients with creatinine clearance below 10 mL/min. Renal function should be assessed before starting and monitored periodically during treatment with Adefovir Dipivoxil, particularly in patients with pre-existing renal impairment (see Precautions and Warnings).
Adefovir Dipivoxil is not recommended in children under 12 years of age.
Optimal duration of treatment is not firmly established; therapy is typically continued long-term to maintain viral suppression (see Duration of Treatment). Do not stop Adefovir Dipivoxil without consulting a physician, as severe worsening of hepatitis B has been reported after discontinuation.
The most commonly reported adverse effects with Adefovir Dipivoxil (occurring in approximately 3% or more of patients) include:
Less common but serious adverse effects include renal impairment or failure, Fanconi syndrome, proximal renal tubulopathy, muscle weakness/myopathy, osteomalacia (bone softening related to proximal tubulopathy), and pancreatitis. Rare, potentially life-threatening reactions — lactic acidosis with severe hepatomegaly and steatosis, and severe exacerbation of hepatitis B after stopping treatment — are discussed further under Precautions and Warnings.
Seek prompt medical attention for unusual muscle pain/weakness, unexplained weight loss, severe abdominal pain, dark urine, or yellowing of the skin/eyes while taking Adefovir Dipivoxil.
Adefovir Dipivoxil is contraindicated in patients with known hypersensitivity to adefovir dipivoxil or to any component of the formulation.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.